ORLANDO, Fla. — Helping improve patient outcomes by identifying and removing barriers to their care is just one reason AllianceRx Walgreens Prime and Highmark Inc. have joined forces to launch a social determinants of health (SDOH) pilot outreach program. The pilot will kick off with Highmark insurance members who have a multiple sclerosis (MS) diagnosis and use AllianceRx Walgreens
ORLANDO, Fla. — The National Association of Specialty Pharmacy (NASP) has bestowed upon Rick Miller, vice president of clinical and professional services at AllianceRx Walgreens Prime, the Distinguished Service Award at the opening general session of its 2020 annual meeting. The Distinguished Service Award is given to the individual who has made a sustained contribution to
ORLANDO, Fla. — AllianceRx Walgreens Prime has renewed its sponsorship of accredited, web-based continuing education (CE) customized for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists. The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals. “We are proud to
ORLANDO, Fla. — AllianceRx Walgreens Prime announced results from a new study analyzing data from patients prescribed interleukin-17 (IL-17) inhibitors for psoriasis. Patients reported improvements in psoriatic symptoms and demonstrated increased medication adherence after switching to one of the three IL-17 medications included in the study. The study was conducted with Walgreens, a parent company of
ORLANDO, Fla. — AllianceRx Walgreens Prime is sponsoring accredited, web-based continuing education (CE) customized specifically for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists. The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals. As part of its ongoing professional development and
DEERFIELD, Ill. — Walgreens has received a U.S. patent for new proprietary technology that its Walgreens community specialty pharmacists and AllianceRx Walgreens Prime’s specialty pharmacists will use to facilitate communication with and counseling of individuals prescribed oral oncology medicines. The technology will be applied through Walgreens Connected Care Oncology, a process that helps pharmacy customers
DEERFIELD, Ill — Walgreens has received a U.S. patent for new proprietary technology in its Connected Care Oncology specialty pharmacy program. An evidence-based, patient-centered solution, Walgreens Connected Care Oncology focuses on driving medication adherence and improving patient outcomes, and the technology helps guide interactions with patients, helping them to stay on their treatment regimens and manage any
